Skip to main content

ORIGINAL RESEARCH article

Front. Oncol. , 21 January 2021

Sec. Cancer Molecular Targets and Therapeutics

Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.614430

RETRACTED: Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM

Retracted

A retraction of this article was approved in:

  1. Retraction: Establishment of criteria for molecular differential diagnosis of MPC and IPM

    1. Read retraction
Xiaohui Wang,&#x;Xiaohui Wang1,2†Yuan Gong&#x;Yuan Gong3†Jianfei Yao,Jianfei Yao1,2Yan ChenYan Chen1Yuemin LiYuemin Li4Zhen Zeng*Zhen Zeng1*Yinying Lu*Yinying Lu1*Lele Song,,*&#x;Lele Song1,2,4*†
  • 1Department of Oncology, The Fifth Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, China
  • 2The Medical Division, HaploX Biotechnology, Shenzhen, China
  • 3Department of Gastroenterology, The Second Medical Center of the Chinese PLA General Hospital, Beijing, China
  • 4Department of Radiotherapy, The Eighth Medical Center of the Chinese PLA General Hospital, Beijing, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Wang X, Gong Y, Yao J, Chen Y, Li Y, Zeng Z, Lu Y and Song L (2021) Establishment of Criteria for Molecular Differential Diagnosis of MPLC and IPM. Front. Oncol. 10:614430. doi: 10.3389/fonc.2020.614430

Received: 06 October 2020; Accepted: 30 November 2020;
Published: 21 January 2021; Retracted: 20 March 2024.

Edited by:

Giuseppe Giaccone, Cornell University, United States

Reviewed by:

Fabio Tavora, Federal University of Ceara, Brazil
Zisis Kozlakidis, International Agency For Research On Cancer (IARC), France

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

Man ultramarathon runner in the mountains he trains at sunset

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more